Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabinoid-1 (CB1) Receptor Positron Emission Tomography (PET) Imaging Reveals Gender Differences in Posttraumatic Stress Disorder (PTSD)

NCT02237677 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02237677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02237677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabinoid-1 (CB1) Receptor Positron Emission Tomography (PET) Imaging Reveals Gender Differences in Posttraumatic Stress Disorder (PTSD)
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Terminated
Start date
June 30, 2012
Completion date
March 31, 2016
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorder (ptsd)